130 related articles for article (PubMed ID: 37638000)
1. Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis.
Sakakibara N; Clavijo PE; Sievers C; Gray VC; King KE; George AL; Ponnamperuma RM; Walter BA; Chen Z; Van Waes C; Allen CT; Weinberg WC
Front Immunol; 2023; 14():1200970. PubMed ID: 37638000
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes.
Ha L; Ponnamperuma RM; Jay S; Ricci MS; Weinberg WC
PLoS One; 2011; 6(7):e21877. PubMed ID: 21789189
[TBL] [Abstract][Full Text] [Related]
3. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
[TBL] [Abstract][Full Text] [Related]
4. Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15
Chen SMY; Li B; Nicklawsky AG; Krinsky AL; Brunetti T; Woolaver RA; Wang X; Chen Z; Young CD; Gao D; Wang XJ; Wang JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916850
[TBL] [Abstract][Full Text] [Related]
5. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
7. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice.
Nguyen KA; DePledge LN; Bian L; Ke Y; Samedi V; Berning AA; Owens P; Wang XJ; Young CD
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37734878
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma.
He JY; Huo FY; Tang HC; Liu B; Bu LL
Int Rev Cell Mol Biol; 2023; 375():33-92. PubMed ID: 36967154
[TBL] [Abstract][Full Text] [Related]
11. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
12. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
[TBL] [Abstract][Full Text] [Related]
13. RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma.
Rampias T; Giagini A; Siolos S; Matsuzaki H; Sasaki C; Scorilas A; Psyrri A
Clin Cancer Res; 2014 Jun; 20(11):2933-46. PubMed ID: 24696319
[TBL] [Abstract][Full Text] [Related]
14. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
[TBL] [Abstract][Full Text] [Related]
15. VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma.
Liu J; Lin WP; Xiao Y; Yang QC; Bushabu Fidele N; Yu HJ; Sun ZJ
Int Immunopharmacol; 2023 Dec; 125(Pt A):111128. PubMed ID: 37907049
[TBL] [Abstract][Full Text] [Related]
16. Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
Chen SMY; Popolizio V; Woolaver RA; Ge H; Krinsky AL; John J; Danis E; Ke Y; Kramer Y; Bian L; Nicklawsky AG; Gao D; Liu S; Chen Z; Wang XJ; Wang JH
J Exp Clin Cancer Res; 2022 Apr; 41(1):123. PubMed ID: 35366939
[TBL] [Abstract][Full Text] [Related]
17. CD73 expression in myeloid-derived suppressor cells is correlated with clinical stages in head and neck squamous cell carcinomas.
Zheng W; Zhu Y; Chen X; Zhao J
Ann Transl Med; 2021 Jul; 9(14):1148. PubMed ID: 34430589
[TBL] [Abstract][Full Text] [Related]
18. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by Hras
Jolly LA; Massoll N; Franco AT
J Clin Cell Immunol; 2016 Oct; 7(5):. PubMed ID: 27942419
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma.
Jiang W; Hu K; Liu X; Gao J; Zhu L
Pathol Oncol Res; 2023; 29():1611210. PubMed ID: 37475874
[TBL] [Abstract][Full Text] [Related]
20. Intersection of the p63 and NF-κB pathways in epithelial homeostasis and disease.
King KE; George AL; Sakakibara N; Mahmood K; Moses MA; Weinberg WC
Mol Carcinog; 2019 Sep; 58(9):1571-1580. PubMed ID: 31286584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]